141 related articles for article (PubMed ID: 6427212)
1. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
Di Giambattista M; Ide G; Engelborghs Y; Cocito C
J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
Nyssen E; Di Giambattista M; Cocito C
Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
[TBL] [Abstract][Full Text] [Related]
4. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
Parfait R; de Béthune MP; Cocito C
Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
[TBL] [Abstract][Full Text] [Related]
5. Action of ions and pH on the binding of virginiamycin S to ribosomes.
Di Giambattista M; Cocito C
Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
Cocito C; Chinali G
J Antimicrob Chemother; 1985 Jul; 16 Suppl A():35-52. PubMed ID: 3932310
[TBL] [Abstract][Full Text] [Related]
7. The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins.
Moureau P; Di Giambattista M; Cocito C
Biochim Biophys Acta; 1983 Mar; 739(2):164-72. PubMed ID: 6402016
[TBL] [Abstract][Full Text] [Related]
8. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
Parfait R; Cocito C
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
[TBL] [Abstract][Full Text] [Related]
9. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
[TBL] [Abstract][Full Text] [Related]
10. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
Parfait R; Di Giambattista M; Cocito C
Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
[TBL] [Abstract][Full Text] [Related]
11. The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
Chinali G; Moureau P; Cocito CG
J Biol Chem; 1984 Aug; 259(15):9563-8. PubMed ID: 6430902
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo inactivation of ribosomes by virginiamycin M does not entail an alteration of 5, 16 and 23 S ribosomal RNA.
Cocito C; Vanlinden F; Branlant C
Biochim Biophys Acta; 1983 Mar; 739(2):158-63. PubMed ID: 6402015
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tryptophan residues of cytochrome P450scc with a highly specific fluorescence quencher, a substrate analogue, compared to acrylamide and iodide.
Lange R; Anzenbacher P; Müller S; Maurin L; Balny C
Eur J Biochem; 1994 Dec; 226(3):963-70. PubMed ID: 7813487
[TBL] [Abstract][Full Text] [Related]
15. Ribosome protection by tRNA derivatives against inactivation by virginiamycin M: evidence for two types of interaction of tRNA with the donor site of peptidyl transferase.
Chinali G; Di Giambattista M; Cocito C
Biochemistry; 1987 Mar; 26(6):1592-7. PubMed ID: 3109469
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
Chinali G; Nyssen E; Di Giambattista M; Cocito C
Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
Di Giambattista M; Chinali G; Cocito C
J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
[TBL] [Abstract][Full Text] [Related]
18. Interaction between virginiamycin S and ribosomes is partly provided by a salt bridge with a Mg2+ ion.
Di Giambattista M; Engelborghs Y; Nyssen E; Clays K; Cocito C
Biochemistry; 1991 Jul; 30(29):7277-82. PubMed ID: 1906740
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
[TBL] [Abstract][Full Text] [Related]
20. Affinity labeling of the virginiamycin S binding site on bacterial ribosome.
Di Giambattista M; Nyssen E; Pecher A; Cocito C
Biochemistry; 1990 Oct; 29(39):9203-11. PubMed ID: 2125475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
